1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Outcomes of patients older than 60 years with acute lymphoblastic leukemia: Survey from the Surveillance, Epidemiology, and End Results (SEER) program
    Meeting Abstract

    Park, J. H.; Devlin, S.; Tallman, M. S.; Douer, D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Carboplatin dosing in the treatment of epithelial ovarian cancer (EOC): A Gynecologic Oncology Group (GOG) study
    Meeting Abstract

    O'Cearbhaill, R. E.; Miller, A.; Muggia, F.; Smith, J. A.; Bookman, M. A.; Sabbatini, P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report
    Meeting Abstract

    Mathew, S.; Harnicar, S.; Halton, E.; Berman, E.; Brentjens, R. J.; Heaney, M. L.; Jurcic, J. G.; Lamanna, N.; Maslak, P. G.; Rosenblat, T. L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Relapse-specific mutations in cytosolic 5 '-nucleotidase II in childhood acute lymphoblastic leukemia
    Meeting Abstract

    Meyer, J.; Wang, J.; Hogan, L. E.; Patel, J.; Tang, Z.; Zumbo, P.; Li, S.; Zavadil, J.; Levine, R. L.; Cardozo, T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A new paradigm in CLL: Minimizing toxicity by using the minimum effective dose (MED) of lenalidomide for older patients with CLL
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Maslak, P. G.; Jurcic, J. G.; Rosenblat, T. L.; Noy, A.; Palomba, M. L.; Weiss, M. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A comparison of CR versus CRi response following CPX-351 treatment of newly diagnosed AML in elderly patients (pts)
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D.; Kolitz, J. E.; Tallman, M. S.; Chiarella, M.; Louie, A. C.; Feldman, E. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Characteristics and outcomes of extranodal NK/t-cell lymphoma (ENKL): A North American (NA) multi-institutional experience
    Meeting Abstract

    Maeda, L. S.; Geiger, J. L.; Savage, K. J.; Rose, J.; Pinter-Brown, L. C.; Lunning, M. A.; Abramson, J. S.; Bartlett, N.; Vose, J.; Drape, J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
    Meeting Abstract

    Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save